MLchartDataset catalogue

HGS-ETR2

Term · Oncology and biomedicine · MLC-T-ONC-003873

A substance being studied in the treatment of some types of cancer. It binds to a protein called TRAIL-R2 on the surface of some tumor cells, which may kill the tumor cells. HGS-ETR2 is a type of monoclonal antibody. Also called anti-TRAIL R2 mAb HGS-ETR2 and lexatumumab.

Table 1. Record
IdentifierMLC-T-ONC-003873
FieldOncology and biomedicine
Expansionsanti-TRAIL R2 mAb HGS-ETR2; lexatumumab
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-003873",
  "term": "HGS-ETR2",
  "field": "Oncology and biomedicine",
  "definition": "A substance being studied in the treatment of some types of cancer. It binds to a protein called TRAIL-R2 on the surface of some tumor cells, which may kill the tumor cells. HGS-ETR2 is a type of monoclonal antibody. Also called anti-TRAIL R2 mAb HGS-ETR2 and lexatumumab.",
  "expansions": [
    "anti-TRAIL R2 mAb HGS-ETR2",
    "lexatumumab"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/hgs-etr2/"
}

Record 8,481 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.